Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. ETF
  3. MDGL
MDGL logo

MDGL

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewTechnicalNews
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

MDGL News

Three Biotech Companies Worth Watching

5d agoNASDAQ.COM

Three Biotech Stocks Worth Watching

5d agoFool

Analysis of XBI ETF Trading Dynamics

Apr 07 2026NASDAQ.COM

Avaí Bio Initiates Master Cell Bank Manufacturing

Apr 01 2026Newsfilter

Avaí Bio Initiates Master Cell Bank Manufacturing

Apr 01 2026PRnewswire

MDGL Stock Rises Significantly in a Month Amid Eli Lilly Acquisition Rumors

Mar 26 2026stocktwits

Wall Street Declines Amid Rising U.S.-Iran Tensions

Mar 26 2026seekingalpha

Madrigal Pharmaceuticals Shares Surge 12% Amid Takeover Speculation

Mar 26 2026seekingalpha

U.S. Markets Declined on Thursday; Karman Holdings Experienced Largest Loss

Mar 26 2026Barron's

Summit Therapeutics Faces FDA Review Risk for Ivonescimab

Mar 25 2026Fool

Summit Therapeutics Faces FDA Approval Risk for Ivonescimab

Mar 25 2026NASDAQ.COM

Avaí Bio Initiates Key Cell Bank Project for Therapy Development

Mar 24 2026PRnewswire

Avaí Bio Initiates Key Cell Bank Project for Therapy Development

Mar 24 2026Newsfilter

RTW Investments Takes New Stake in Apellis Pharmaceuticals

Mar 22 2026Yahoo Finance

RTW Investments Increases Stake in Cogent Biosciences by $116 Million

Mar 22 2026Yahoo Finance

Undervalued Investment Opportunities: Axsome and Madrigal

Mar 10 2026Fool